Insulin and New Insulin Analogues, Insulin Pumps and Inhaled Insulin in Type 1 Diabetes

Andrea Siebenhofer, Johannes Plank, Andrea Berghold, Klaus Jeitler, Karl Horvath, Markus Narath, Robert Gfrerer, Thomas R Pieber, Short acting insulin analogues versus regular human insulin in patients with diabetes mellitus. Cochrane Database of Systematic Reviews. ,(2006) , 10.1002/14651858.CD003287.PUB4

R. E. Ratner, I. B. Hirsch, J. L. Neifing, S. K. Garg, T. E. Mecca, C. A. Wilson, Less hypoglycemia with insulin glargine in intensive insulin therapy for type 1 diabetes. U.S. Study Group of Insulin Glargine in Type 1 Diabetes. Diabetes Care. ,vol. 23, pp. 639- 643 ,(2000) , 10.2337/DIACARE.23.5.639

Lisa Ceglia, Joseph Lau, Anastassios G. Pittas, Meta-Analysis: Efficacy and Safety of Inhaled Insulin Therapy in Adults with Diabetes Mellitus Annals of Internal Medicine. ,vol. 145, pp. 665- 675 ,(2006) , 10.7326/0003-4819-145-9-200611070-00009

T. R. Pieber, I. Eugene-Jolchine, E. Derobert, Efficacy and safety of HOE 901 versus NPH insulin in patients with type 1 diabetes. The European Study Group of HOE 901 in type 1 diabetes. Diabetes Care. ,vol. 23, pp. 157- 162 ,(2000) , 10.2337/DIACARE.23.2.157

S. G. Ashwell, S. A. Amiel, R. W. Bilous, U. Dashora, S. R. Heller, D. A. Hepburn, S. D. Shutler, J. W. Stephens, P. D. Home, Improved glycaemic control with insulin glargine plus insulin lispro: a multicentre, randomized, cross‐over trial in people with Type 1 diabetes Diabetic Medicine. ,vol. 23, pp. 285- 292 ,(2006) , 10.1111/J.1464-5491.2005.01781.X

G. B. Bolli, R. D. Di Marchi, G. D. Park, S. Pramming, V. A. Koivisto, Insulin analogues and their potential in the management of diabetes mellitus. Diabetologia. ,vol. 42, pp. 1151- 1167 ,(1999) , 10.1007/S001250051286

Philip Home, Paul Bartley, David Russell-Jones, Hélène Hanaire-Broutin, Jan-Evert Heeg, Pascale Abrams, Mona Landin-Olsson, Birgitte Hylleberg, Hanne Lang, Eberhard Draeger, Study to Evaluate the Administration of Detemir Insulin Efficacy, Safety and Suitability (STEADINESS) Study Group, None, Insulin Detemir Offers Improved Glycemic Control Compared With NPH Insulin in People With Type 1 Diabetes: A randomized clinical trial. Diabetes Care. ,vol. 27, pp. 1081- 1087 ,(2004) , 10.2337/DIACARE.27.5.1081

K. H. Tseng, Standards of medical care in diabetes--2006: response to the American Diabetes Association. Diabetes Care. ,vol. 29, pp. 2563- 2564 ,(2006) , 10.2337/DC06-0805

H. C. Hagedorn, Landmark article Jan 18, 1936: Protamine insulinate. By H.C. Hagedorn, B.N. Jensen, N.B. Krarup, and I. Wodstrup JAMA: The Journal of the American Medical Association. ,vol. 251, pp. 389- 392 ,(1984) , 10.1001/JAMA.251.3.389

I. De Leeuw, P. Vague, J.-L. Selam, S. Skeie, H. Lang, E. Draeger, J. W. F. Elte, Insulin detemir used in basal‐bolus therapy in people with type 1 diabetes is associated with a lower risk of nocturnal hypoglycaemia and less weight gain over 12 months in comparison to NPH insulin Diabetes, Obesity and Metabolism. ,vol. 7, pp. 73- 82 ,(2005) , 10.1111/J.1463-1326.2004.00363.X